These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26632932)
21. Disseminated superficial porokeratosis in a patient with cholangiocarcinoma: a paraneoplastic manifestation? Torres T; Velho GC; Selores M An Bras Dermatol; 2010; 85(2):229-31. PubMed ID: 20520941 [TBL] [Abstract][Full Text] [Related]
22. [Porokeratosis Mibelli gigantea: case report and literature review]. Götz A; Kopera D; Wach F; Hohenleutner U; Landthaler M Hautarzt; 1999 Jun; 50(6):435-8. PubMed ID: 10427514 [TBL] [Abstract][Full Text] [Related]
23. Porokeratosis in Singapore: an Asian perspective. Tan LS; Chong WS Australas J Dermatol; 2012 May; 53(2):e40-4. PubMed ID: 22571584 [TBL] [Abstract][Full Text] [Related]
24. Porokeratosis in immunosuppressed and nonimmunosuppressed patients. Raychaudhuri SP; Smoller BR Int J Dermatol; 1992 Nov; 31(11):781-2. PubMed ID: 1428428 [TBL] [Abstract][Full Text] [Related]
25. Disseminated superficial actinic porokeratosis on the face treated with imiquimod 5% cream. Riad H; Mansour K; Sada HA; Shaika SA; Ansari HA; Mohannadi HA Case Rep Dermatol; 2013; 5(3):283-9. PubMed ID: 24403891 [TBL] [Abstract][Full Text] [Related]
26. The hyperkeratotic variant of porokeratosis Mibelli is a distinct entity: clinical and ultrastructural evidence. Schaller M; Korting HC; Kollmann M; Kind P Dermatology; 1996; 192(3):255-8. PubMed ID: 8726642 [TBL] [Abstract][Full Text] [Related]
27. Porokeratosis of the lower lip. Vergara G; Bañuls J; Botella R; Silvestre JF; Belinchón I; Betlloch I Eur J Dermatol; 2002; 12(5):500-2. PubMed ID: 12370146 [TBL] [Abstract][Full Text] [Related]
28. Porokeratoses: an update of clinical, aetiopathogenic and therapeutic features. Kanitakis J Eur J Dermatol; 2014; 24(5):533-44. PubMed ID: 25115203 [TBL] [Abstract][Full Text] [Related]
29. A rare case of disseminated superficial porokeratosis-Case report. Ramakrishnan R; Vignesh TA; Durai PCT; Narasimhan M J Family Med Prim Care; 2022 Mar; 11(3):1195-1197. PubMed ID: 35495808 [TBL] [Abstract][Full Text] [Related]
30. Etanercept in the treatment of psoriasis and psoriatic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients. Zanni M; Missale G; Santilli D; Di Nuzzo S Eur J Dermatol; 2011; 21(4):564-7. PubMed ID: 21543290 [TBL] [Abstract][Full Text] [Related]
31. Challenges in the Diagnosis and Management of Giant Porokeratosis: A Case Report. Portelli MG; Bălăceanu-Gurău B; Orzan OA; Zurac SA; Tudose I Cureus; 2024 Feb; 16(2):e55155. PubMed ID: 38558715 [TBL] [Abstract][Full Text] [Related]
33. Follicular Porokeratosis, a Porokeratosis Variant. Tallon B; Emanuel P Am J Dermatopathol; 2017 Aug; 39(8):e107-e109. PubMed ID: 28266938 [TBL] [Abstract][Full Text] [Related]
34. Squamous cell carcinoma arising from lesions of porokeratosis palmaris et plantaris disseminata. Seishima M; Izumi T; Oyama Z; Maeda M Eur J Dermatol; 2000 Aug; 10(6):478-80. PubMed ID: 10980475 [TBL] [Abstract][Full Text] [Related]
35. Simultaneous development and parallel course of disseminated superficial porokeratosis and ovarian cancer: Coincidental association or true paraneoplastic syndrome? Cannavó SP; Borgia F; Adamo B; Guarneri B J Am Acad Dermatol; 2008 Apr; 58(4):657-60. PubMed ID: 18258333 [TBL] [Abstract][Full Text] [Related]
36. Pigmented Porokeratosis. A Further Variant? Tan TS; Tallon B Am J Dermatopathol; 2016 Mar; 38(3):218-21. PubMed ID: 26894774 [TBL] [Abstract][Full Text] [Related]